|
2025
|
P/S
|
Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorde... |
|
|
P/S
|
Biological and pharmaceutical preparations for the treatment
of cancer and immune-related disord... |
|
2024
|
Invention
|
Compounds useful in the modulation of klhdc1 and klhdc2 activity. ex vivoin vitroin vivoin vivo m... |
|
|
Invention
|
Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereof.
Compounds,... |
|
|
Invention
|
Salts and free bases of bifunctional compound and polymorph forms thereof.
The present disclosur... |
|
|
Invention
|
Salts and free bases of bifunctional compound and polymorph forms thereof. The present disclosure... |
|
|
Invention
|
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof.
The pres... |
|
|
Invention
|
Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof.
Compounds, compositions, and m... |
|
|
Invention
|
Bifunctional selective degraders of smarca2 and therapeutic uses thereof.
The present disclosure... |
|
|
Invention
|
Bifunctional azines conjogates as selective degraders of smarca2 and therapeutic uses thereof. Th... |
|
|
Invention
|
Combination therapies with cbl-b inhibitor compounds.
The present disclosure relates to combinat... |
|
|
Invention
|
Bifunctional compounds for degrading braf via ubiquitin proteosome pathway. This disclosure relat... |
|
|
Invention
|
Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associa... |
|
|
Invention
|
3-substituted piperidine compounds for cbl-b inhibition, and use thereof.
Compounds, composition... |
|
2023
|
Invention
|
Bifunctional compounds for degrading btk via ubiquitin proteosome pathway.
The present invention... |
|
|
Invention
|
Biomarkers for cbl, and compositions and methods for their use.
Provided herein are biomarkers, ... |
|
|
Invention
|
Combination therapies with cbl-b inhibitor compounds and antiemetic agents.
The present disclosu... |
|
|
Invention
|
Combination therapies with cbl-b inhibitor compounds and antiemetic agents. The present disclosur... |
|
|
Invention
|
Biomarkers for cbl, and compositions and methods for their use. in vivoin vivo samples. |
|
|
Invention
|
Bifunctional compounds for degrading btk via ubiquitin proteosome pathway.
This disclosure relat... |
|
2022
|
Invention
|
Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof. Compounds, compositions, and me... |
|
|
Invention
|
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof. The prese... |
|
|
Invention
|
Toll-like receptor therapy combinations with cbl-b inhibitor compounds.
The present disclosure r... |
|
|
Invention
|
Toll-like receptor therapy combinations with cbl-b inhibitor compounds. The present disclosure re... |
|
|
Invention
|
Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and for degrading bt... |
|
|
Invention
|
Bifunctional compounds for degrading itk via ubiquitin proteosome pathway. This disclosure relate... |
|
|
Invention
|
Compounds for inhibiting or degrading target proteins, compositions, comprising the same, methods... |
|
|
Invention
|
Bifunctional compounds for degrading btk via ubiquitin proteosome pathway. The present invention ... |
|
|
Invention
|
Bifunctional compounds for degrading btk with enhanced imid activity.
This disclosure relates to... |
|
|
Invention
|
Bifunctional compounds for degrading btk with enhanced imid activity. This disclosure relates to ... |
|
|
Invention
|
Bifunctional compounds for degrading btk with diminished imid activity.
This disclosure relates ... |
|
|
Invention
|
Bifunctional compounds for degrading btk with diminished imid activity. This disclosure relates t... |
|
|
Invention
|
3-substituted piperidine compounds for cbl-b inhibition, and use thereof. Compounds, compositions... |
|
|
Invention
|
Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereof. Compounds, ... |
|
|
Invention
|
Compounds for inhibiting or degrading itk, compositions, comprising the same methods of their mak... |
|
|
Invention
|
Combination therapies with cbl-b inhibitor compounds. The present disclosure relates to combinati... |
|
2021
|
Invention
|
Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof. ... |
|
2020
|
Invention
|
Urea, amide, and substituted heteroaryl compounds for cbl-b inhibition.
Compounds of formulae (I... |
|
|
P/S
|
Research and development in the pharmaceutical and biotechnology fields. |
|
|
P/S
|
Research and development in the pharmaceutical and
biotechnology fields. |
|
|
P/S
|
Research and development of biological and pharmaceutical drugs to treat diseases utilizing a pro... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer and autoimmune diseases. |
|
2019
|
P/S
|
Research and development in the pharmaceutical and biotechnology fields |
|
|
Invention
|
Bifunctional compounds for grading btk via ubiquitin proteosome pathway.
The present invention r... |
|
|
P/S
|
Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders |
|
|
Invention
|
Inhibitors of cbl-b and methods of use thereof.
Compounds, compositions, and methods for use in ... |
